Identification |
Name: | 1H-Indole-5-ethanesulfonamide,N-methyl-3-(1-methyl-4-piperidinyl)- |
Synonyms: | N-Methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide;Naratriptan(Amerge); |
CAS: | 121679-13-8 |
Molecular Formula: | C17H25N3O2S |
Molecular Weight: | 252.30774 |
InChI: | InChI=1/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 281.2°C |
Boiling Point: | 541.3°C at 760 mmHg |
Density: | 1.227g/cm3 |
Refractive index: | 1.605 |
Specification: |
Naratriptan , its cas register number is 121679-13-8. It also can be called N-Methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide ; 1H-indole-5-ethanesulfonamide, N-Methyl-3-(1-methyl-4-piperidinyl)- naratriptan .
Naratriptan (trade names include Amerge and Naramig) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-hydroxytryptamine1 receptor subtype agonist. Naratriptan hydrochloride is chemically designated as N-methyl-3-( 1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide.
|
Flash Point: | 281.2°C |
Safety Data |
|
|